ADT1130-Cetuximab Biosimilar– Anti-EGFR mAb – Research Grade

EGFR (Epidermal Growth Factor Receptor) is a Protein Coding gene. Diseases associated with EGFR include Inflammatory Skin And Bowel Disease, Neonatal, 2 and Lung Cancer. Among its related pathways are Apoptotic Pathways in Synovial Fibroblasts and Prolactin Signaling. Gene Ontology (GO) annotations related to this gene include identical protein binding and protein kinase activity. An important paralog of this gene is ERBB2.Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses.Known ligands include EGF, TGFA/TGF-alpha, AREG, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF.Ligand binding triggers receptor homo- and/or heterodimerization and autophosphorylation on key cytoplasmic residues.

By maintaining stringent quality control throughout the production process, we provide blocking antibody that meet the highest standards of purity and performance, making them ideal for research applications.

Request a Quote

Contact us

Please feel free to give your inquiry in the form below We will reply you in 24 hours

Leave YourMessage

Thank you! We will reply you via email within 24 hours.

Return